StonvexLoading…
StonvexStonvexStonvexCore line items from NG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2021 2021-11-30 | Annual 2020 2020-11-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-47.29M | $-37.86M | $-36.84M | $-33.24M |
Net Income | $-94.66M | $-45.62M | $-40.54M | $-33.56M |
EPS (Diluted) | $-0.25 | $-0.14 | $-0.12 | $-0.10 |
Total Assets | $335.91M | $109.75M | $198.85M | $224.44M |
Total Liabilities | $172.12M | $157.17M | $120.57M | $113.71M |
Cash & Equivalents | $110.14M | $42.22M | $91.12M | $60.91M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 406.93M | 334.57M | 332.42M | 330.40M |